title: The effect of controlling inflammatory activity in the colon on the response to infliximab of autoimmune haemolytic anaemia associated with ulcerative colitis.
authors: E
authors: E
authors: Leo-Carnerero
authors: A
authors: A
authors: Araujo-Míguez
authors: C
authors: C
authors: Trigo-Salado
authors: M D
authors: MD
authors: De-la-Cruz-Ramírez
authors: J M
authors: JM
authors: Herrera-Justiniano
authors: J L
authors: JL
authors: Márquez-Galán
mesh_terms: D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy* / Q000209:etiology; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D003092:Colitis / Q000209:etiology* / Q000628:therapy*; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D013256:Steroids / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D013256:Steroids; D000069285:Infliximab